Therefore, we performed this multi-institutional retrospective analysis aiming to investigate the prognostic efficacy of a combination of preoperative serum Alb and BCHE levels, which we designed as a new biomarker of the prognosis for patients who underwent hepatic resection for HCC. The gene discussed is BCHE; the disease is hepatocellular carcinoma.